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Abstract The expression level of CC-chemokine recep-
tor 5 (CCR5) is enhanced post inflammatory stimulations
and might play a crucial role on inflammatory cells infil-
tration post myocardial ischemia. The purpose of this study
was to evaluate the role of CCR5 on myocardial ischemia–
reperfusion (I/R) injury in rats. Adult male rats were ran-
domized to sham group, I/R group (I/R, 30 min coronary
artery occlusion followed by 2-h reperfusion), ischemic
preconditioning (I/R ? Pre), CCR5 antibody group [I/R ?
CCR5Ab (0.2 mg/kg)], and CCR5 agonist group [I/R ?
CCR5Ago, RNATES (0.1 mg/kg)], n = 12 each group.
The serum level of creatine kinase (CK) and tumor necrosis
factor a (TNF-a) were measured by ELISA. Myocardial
infarction size and myeloperoxidase (MPO) activity were
determined. Myocardial protein expression of CCR5 and
intercellular adhesion molecule-1 (ICAM-1) were evalu-
ated by Western blotting and immunohistochemistry staining,
respectively. Myocardial nuclear factor-kappa B (NF-jB)
activity was assayed by electrophoretic mobility shift assay.
Myocardial CCR5 protein expression was significantly
reduced in I/R ? Pre group (P \ 0.05 vs. I/R) and further
reduced in I/R ? CCR5Ab group (P \ 0.05 vs. I/R ? Pre).
LVSP and ±dP/dtmax were significantly lower while serum
CK and TNF-a as well as myocardial MPO activity, ICAM-1
expression, and NF-jB activity were significantly higher in
I/R group than in sham group (all P \ 0.05), which were
significantly reversed by I/R ? Pre (all P \ 0.05 vs. I/R) and
I/R ? CCR5Ab (all P \ 0.05 vs. I/R ? Pre) while aggra-
vated by I/R ? CCR5Ago (all P \ 0.05 vs. I/R). Our results
suggest that blocking CCR5 attenuates while enhancing
CCR5 aggravates myocardial I/R injury through modulating
inflammatory responses in rat heart.
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Introduction
Reperfusion strategies have substantially contributed to the
effective treatment of ischemic heart diseases despite the
potential negative impact of ischemia/reperfusion (I/R)
injury[1]. I/R injury is characterized by robust local and
systemic inflammatory responses which may aggravate
tissue injury and adversely affect left ventricular (LV)
recovery [2]. A variety of studies in the last decades has
shown that the extent of postischemic tissue damage
strongly correlates with the number of leukocytes recruited
to the reperfused tissue [3–5]. It is known that increased
chemokine expression post I/R could promote the adhesion
of neutrophils and increase leukocyte infiltration in the
cardiac tissue [6], which could serve as one of the impor-
tant mechanisms mediating the ischemic myocardial
damage. Over the past years, chemokines and their recep-
tors have become the subject of intensive investigations
and there is a growing body of evidence that chemokines
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and their receptors are also critically involved in the
pathogenesis of I/R. Chemokines are small, secreted pro-
teins that are produced constitutively or in an inducible
manner by most cell types and that induce directed cell
migration [7]. CC-chemokine receptor 5 (CCR5) is
expressed on T-lymphocytes with memory/effector phe-
notype, macrophages, monocytes, as well as the immature
dendritic cells [8]. The expression levels of CCR5 are very
low in the mononuclear cells and T cells of human
peripheral blood under normal conditions, but could
increase significantly after the inflammatory stimulation
both in vivo and in vitro [9]. Previous study showed that
TAK-779, a small-molecule, nonpeptide compound that
selectively binds to a certain subtype of the CC-chemokine
receptor, CCR5, with high affinity [10], could effectively
reduce leukocyte infiltration of the reperfused tissue and
attenuate subsequent postischemic organ failure in mouse
models of focal cerebral ischemia [11]. In this study, we
tested the hypothesis that myocardial I/R injury could be
attenuated by CCR5 antibody or aggravated by CCR5
agonist RANTES in rats.
Materials and methods
Animals and reagents
Healthy adult male Wistar rats (200–250 g) were pur-
chased from Vital River Laboratories, Beijing, China. All
experiments were approved by the Institutional Animal
Care and Use Committee of Wuhan University. CCR5
antibody and CCR5 agonist RANTES were purchased from
Sigma (USA); creatine kinase (CK) and myeloperoxidase
(MPO) kit were purchased from Nanjing Jiancheng Bio-
engineering Institute (China). TNF-a ELISA kit was pur-
chased from Wuhan Boster Bioengineering Co. Ltd.
(China). Electrophoretic mobility shift assay (EMSA) kit
was purchased from Promega Corp. (Madison, WI, USA).
Surgical preparation
The surgical protocol was performed as described previously
[12]. The rats were anesthetized with an intraperitoneal
injection of sodium pentobarbital (35 mg/kg). After endotra-
cheal intubation with a 14 gauge tube, the rats were then
connected to a rodent respirator (TKR-400H, Jiangxi, China,
70 breaths per minute, tidal volume was set to 1.0 ml/100 mg
body weight). Body temperature was measured by a rectal
thermometer and maintained between 36 and 37 C by
infrared heating lamp. Hemodynamics (left ventricular sys-
tolic pressure (LVSP); left ventricular end-diastolic pressure
(LVEDP); and heart rate (HR), ?dP/dtmax and -dP/dtmax)
were measured through a short segment of saline-filled PE50
tubing which was advanced to left ventricle through right
carotid artery and connected to a multi-channel physiological
monitoring system (LEAD 2000, Sichuan, China) before left
anterior descending coronary artery (LAD) ligation or sham
operation. Hemodynamic parameters were obtained immedi-
ately after 2-h reperfusion. Electrocardiograph (ECG) leads
were connected to the chest and limbs for continuous ECG
monitoring throughout the experiment (LEAD 2000, Sichuan,
China). Then, the chest was opened via left thoracotomy
through the fourth or fifth intercostal space, and the ribs were
gently retracted to expose the heart. A 7-0 prolene suture was
placed under left anterior descending coronary artery (LAD)
after pericardiotomy.
Experimental protocol
Sixty rats were randomly divided into five groups: sham
operation group (SHAM, n = 12), I/R group (I/R, n = 12),
ischemic preconditioning group (I/R ? Pre, n = 12), CCR5
antibody group (I/R ? CCR5Ab, n = 12), and CCR5 ago-
nist (RANTES) group (I/R ? CCR5Ago, n = 12). Each
group was subjected to 30 min of coronary artery occlusion
followed by 2 h of reperfusion except sham group. (1)
SHAM group: 0.1 ml of anhydrous ethanol was bolus
injected through the external jugular vein after thoracotomy
and LAD was not ligated; (2) I/R group: LAD ligation for
30 min followed by 2-h reperfusion, 0.1 ml of anhydrous
ethanol was bolus injected through the external jugular vein
after thoracotomy and after 20-min ischemia; (3) I/R ? Pre
group: two cycles of 5-min ischemia followed by 5-min
reperfusion and one cycle of 10-min ischemia followed by
10-min reperfusion, 0.1 ml of anhydrous ethanol was bolus
injected through the external jugular vein before the 3rd
circle reperfusion; (4) I/R ? CCR5Ab group [13]: LAD
ligation for 30 min followed by 2-h reperfusion, 0.2 mg/kg
CCR5 antibody diluted in 0.1 ml of anhydrous ethanol was
bolus injected through the external jugular vein after tho-
racotomy and after 20-min ischemia; (5) I/R ? CCR5Ag
group [14]: LAD ligation for 30 min followed by 2-h
reperfusion, 0.1 mg/kg RANTES diluted in 0.1 ml of
anhydrous ethanol was bolus injected through the external
jugular vein after thoracotomy and after 20-min ischemia.
For each individual group, six rats were assigned for myo-
cardial MPO activity determination and measurement of
infarct zone and risk area and another 6 rats were assigned
for myocardial inflammatory cells counting in HE-stained
slices, myocardial CCR5 and ICAM-1 expression, and
NF-jB activity determination.
Measurement of infarct zone and risk area
Immediately after hemodynamic measurements, LAD was
re-occluded with a 7-0 prolene suture which was used
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previously at the same place for rats assigned for myo-
cardial MPO activity determination and measurement of
infarct zone and risk area, and Evans blue dye (2 ml of a
1 % solution) was injected via the external jugular vein to
delineate the area at risk (AAR). The rats were sacrificed
under deep pentobarbital anesthesia (60 mg/kg, i.p.) after
blood sampling. The heart was then rapidly excised and
washed in 0.9 % saline. After removal of the atrium, the
ventricle was cut into transverse slices of equal thickness
(3 mm) from the apex to the base. The slices were then
incubated for 20 min in phosphate-buffered 1 % 2,3,5-tri-
phenyltetrazolium chloride (TTC) at 37 C, and then fixed
in 10 % formalin solution. The AAR was defined as the
area not stained with Evans blue dye. The area not stained
by TTC was defined as the infarcted zone (AI). The border
zones (Evans blue stained area neighboring Evans blue-
unstained area), infarcted zones [TTC and The border
zones (TTC-stained), infarcted zones (TTC and Evans
blue-unstained)], and the nonischemic zones (Evens blue-
unstained area remote from Evans blue-unstained area)
were photographed and analyzed by the software program
Image J 1.36. The AAR, AI, and ventricle size (VS) were
assessed by a technician who was blinded to the experi-
mental protocol using computer-assisted planimetry (NIH
Image 1.57 software).
The infarct zone, border zones, and risk area were dig-
ital recorded. The percentage of the ischemic region (AR)
in the whole LV (AR/LV) represents the severity of
myocardial ischemia. The percentage of the infarcted
region (IS) in the whole ischemic region (AR) (IS/AR)
represents the extent of myocardial infarction. The three
parts of LV samples (nonischemic zone, border zone, and
infract zone) were stored in -80 C refrigerator for
determining MPO activity.
Blood collection of tissue sampling
After hemodynamic measurements, 4-ml blood was
obtained from the carotid artery of all rats. Blood samples
were placed static for 30 min at room temperature, and
then centrifuged at 4,000 r/min for 10 min at 4 C. The
upper serum was removed into new EP tubes and stored in
-80 C refrigerator for detection of CK and TNF-a.
For rats assigned myocardial inflammatory cells count-
ing in HE-stained slices, myocardial CCR5 and ICAM-1
expression, and NF-jB binding activity determination, rats
were sacrificed under deep pentobarbital anesthesia
(60 mg/kg, i.p.) after blood sampling, hearts were excised
and washed with ice-cold saline solution. Two transversal
sections (3-mm thick) from the middle part of each heart
were prepared and stained with hematoxylin–eosin (HE)
for evaluation of the inflammatory response in the cardiac
tissues. Severity of inflammatory cell infiltration on HE
staining was scored using the following scale [15]: 0 = no
inflammation; 1 = cellular infiltrates only around blood
vessel and meninges; 2 = mild cellular infiltrates in
parenchyma (1–10/section); 3 = moderate cellular infil-
trates in parenchyma (11–100/section); 4 = serious cellu-
lar infiltrates in parenchyma (100/section).
The remaining LV free wall was divided into three parts.
One portion of LV free wall was used for the determination
of myocardial ICAM-1 and fixed in 4 % paraformalde-
hyde. The second portion of LV free wall was stored in
-80 C refrigerator until use for NF-jB binding activity
determination. The third portion was stored in -80 C
refrigerator until use for myocardial CCR5 protein
expression determination.
Determination of Serum CK, TNF-a, and myocardial
MPO activity
Serum CK level was determined by chemical colorimetric
method. The serum level TNF-a was determined by rat
TNF-a ELISA kit, referring to the manual. Tetramethyl
benzidine method was applied for the determination of
myocardial MPO activity.
Immunohistochemistry
Immunohistochemical staining of ICAM-1 was performed
by the Strept Avidin Biotin Complex (SABC) method.
Mouse monoclonal ICAM-1 antibody sc-107 (Santa Cruz
Biotechnology, CA) was diluted at 1:100 as primary anti-
bodies. The streptavidin–biotin complex kit was purchased
from Wuhan Boster Biological Technology, Ltd. Wuhan,
China. All the procedures were carried out according to
the manufacturer’s manual. The data of the extent and
intensity of staining were obtained using Image Pro Plus
Version 6.0 (Media Cybernetics, Bethesda, MD). Five
fields of each slice were photographed and analyzed by
mean optical density.
Electrophoretic mobility shift assay
EMSA method was used to detect the DNA-binding
activities of NF-jB in nuclear extracts. NF-jB oligonu-
cleotide’s sequence was 50-AGTTGAGGGGACTTTCCCA
GGC-30 and 50-GCCTGGGAAAGTCCCCTCAACT-30.
Protein-DNA binding assays were performed with 20 lg of
nuclear protein. In order to block the unspecific binding,
1 lg of poly (dI-dC) • poly (dI-dC) was added to the
samples; then apply the binding medium containing 5 %
glycerol, 1 % NP40, 1 mM MgCl2, 50 mM NaCl, 0.5 mM
EDTA, 2 mM DTT, and 10 mM Tris/HCl, and with its pH
around 7.5. In each reaction, 20,000 cpm of a radiolabeled
probe was included. Samples were incubated at room
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temperature for 20 min. In order to separate the nuclear
protein oligonucleotide complex labeled with 32P from
free 32P-labeled oligonucleotide, the samples were sub-
jected to electrophoresis through a 5 % native polyacryl-
amide gel for 2 h in a running buffer containing 50 mM
Tris, pH 8.0, 45 mM borate, and 0.5 mM EDTA. After the
separation was achieved, the gel was vacuum-dried for
autoradiography and exposed to Fuji X-ray film for
24–48 h at -80 C. The results were analyzed by medical
image analysis system, with its gray-scale value repre-
senting the activity of NF-jB [16].
Western blotting
Western blotting was conducted to determine protein levels
of CCR5 from myocardial tissues. Total cellular membrane
proteins were extracted by Plasma Membrane Protein
Extraction Kit (Catalog #K268-50) according to Membrane
Protein Extraction Protocol. Supernatants were boiled for
10 min in loading buffer, and then separated by SDSPAGE
and transferred onto nitrocellulose membranes. After
blockage with 5 % skim milk in Tris-buffered saline (TBS)
for 1 h at room temperature, the membranes were incubated
with primary antibody at 4 C overnight. After three wash-
ings with TBST, (HRP)-labeled secondary antibodies were
added and incubated for another 1.5 h on the shaker at room
temperature; the blots were then washed two times with
TBST. The developed signal was detected using ECL as per
the manufacturer’s instructions and exposed to Hyperfilm.
Antibodies against CCR5 were obtained from Cell
Signaling Technology (Boston, MA, USA). The antibody
against b-actin was from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Anti-rabbit and anti-mouse HRP-labeled
antibodies and the ECL detection reagents were from Santa
Cruz Biotechnology. The X-ray film used for Western-blot
analysis was from Kodak (Rochester, NY, USA). Other
chemicals and reagents were of analytical grade.
Statistical analysis
Data are presented as mean ± standard deviation (SD).
Normality of distribution of all continuous variables was
explored by examining skewness, kurtosis, and Q–Q plots.
Differences on continuous data among groups were com-
pared using one-way analysis of variance (ANOVA) fol-
lowed by either Tukey’s or Games-Howell multiple
comparison post-hoc tests as appropriate. Variables with
non-normal distribution were compared using the non-
parametric Mann–Whitney U-statistic test. A P value\0.05
was considered statistically significant. Statistical analysis
was performed using IBM SPSS, version 20 for Windows.
Results
Mortality
Five rats died post LAD ligation due to malignant
arrhythmias and the remaining 55 rats were used in the
study and 5–6 rats were examined in each individual group.
Cardiac function
The cardiac function indexes after 2-h reperfusion or
sham operation are shown in Table 1. LVSP, ?dP/dtmax,
and -dP/dtmax were all significantly lower in I/R group
than those in sham group and were significantly higher in
I/R ? Pre group and I/R ? CCR5Ab group while signifi-
cantly lower in I/R ? CCR5Ago group as compared to I/R
group. LVEDP was increased in I/R group than those in
sham group and were significantly reduced in I/R ? Pre
group and I/R ? CCR5Ab group while significantly higher
in I/R ? CCR5Ago group as compared to I/R group.
Serum levels of CK and TNF-a
Similarly, serum levels of CK and TNF-a were both sig-
nificantly higher in I/R group compared to sham group and
were significantly reduced in I/R ? Pre group and
I/R ? CCR5Ab groups while significantly increased in
I/R ? CCR5Ago group compared to I/R group (Fig. 1).
Myocardial infarct size
As shown in Fig. 2, the ischemia region (AR/LV) was similar
among group. The myocardial infarct size was significantly
Table 1 Cardiac function in vivo
n HR (beats/min) LVSP (mmHg) LVEDP (mmHg) ?dP/dtmax (mmHg/s) -dP/dtmax (mmHg/s)
SHAM 12 322 ± 17 139 ± 14 2.6 ± 0.2 7999 ± 772 -5005 ± 711
I/R 11 367 ± 14* 93 ± 6* 7.4 ± 0.5* 4868 ± 525* -2556 ± 444*
I/R ? Pre 10 358 ± 9* 116 ± 6*, 4.1 ± 0.3*, 6316 ± 603*, -3512 ± 551*,
I/R ? CCR5Ab 12 352 ± 10*, 126 ± 5, 4.3 ± 0.38*, 7077 ± 445*,, -4253 ± 666*,,
I/R ? CCR5Ago 10 370 ± 21*,§ 77 ± 6*,,,§ 7.5 ± 0.5*,,§ 2987 ± 685*,,§ -1705 ± 515*,,§
* P \ 0.05 vs. SHAM;  P \ 0.05 vs. I/R;  P \ 0.05 vs. I/R ? Pre; § P \ 0.05 vs. I/R ? CCR5Ab
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smaller in I/R ? Pre group and I/R ? CCR5Ab group while
was significantly larger in I/R ? CCR5Ago group than those
in I/R group, and was significantly smaller in I/R ? CCR5Ab
group as compared to I/R ? Pre group (P\0.05).
MPO activity in myocardial tissues
MPO activities were significantly increased in I/R group
compared to sham group in normal zone; MPO activities
were significantly lower in I/R ? Pre group and
I/R ? CCR5Ab group while was significantly higher in
I/R ? CCR5Ago group in normal, risk and infract zone
than in I/R group (Fig. 3).
Inflammatory levels in myocardial tissues
The extent of inflammation of myocardial tissues from LV
free wall in different groups was examined in HE-stained
transversal myocardial slides. Histopathological images
and histological score are listed in Fig. 4. Myocardial tis-
sue in I/R and I/R ? CCR5Ago groups presented massive
inflammatory cell infiltration as compared to sham group
indicating that I/R injury could trigger the inflammatory
response which was reduced in I/R ? Pre and I/R ?
CCR5Ab group. Accordingly, histological score was sig-
nificantly lower in I/R ? Pre and I/R ? CCR5Ab groups
than in I/R group and higher in I/R ? CCR5Ago group
than in I/R ? Pre and I/R ? CCR5Ab groups.
Myocardial ICAM-1 expression
Brown particles indicated the expression levels of ICAM-1
in myocardial tissues from LV free wall (Fig. 5). Myo-
cardial ICAM-1 expression was significantly upregulated
in I/R group compared to sham group and was significantly
attenuated in I/R ? Pre group and I/R ? CCR5Ab group
Fig. 1 Serum levels of CK and TNF-a. Serum levels of CK and
TNF-a were both significantly higher in I/R group compared to sham
group and were significantly reduced in I/R ? Pre group and
I/R ? CCR5Ab groups while significantly increased in I/R ? CCR5Ago
group compared to I/R group
Fig. 2 Myocardial infarct size. The ischemia region (AR/LV) was
similar among group. The myocardial infarct size was significantly
smaller in I/R ? Pre group and I/R ? CCR5Ab group while was
significantly larger in I/R ? CCR5Ago group than those in I/R group,
and was significantly smaller in I/R ? CCR5Ab group as compared
to I/R ? Pre group (P \ 0.05)
Fig. 3 MPO activity in myocardial tissues. MPO activities were
significantly increased in I/R group compared to sham group in
normal zone, MPO activities were significantly lower in I/R ? Pre
group and I/R ? CCR5Ab group while was significantly higher in
I/R ? CCR5Ago group in normal, risk, and infract zone than in I/R
group
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while was significantly increased in I/R ? CCR5Ago
group compared to that in I/R group.
Myocardial NF-jB binding activity
The myocardial DNA-binding activity of NF-jB was sig-
nificantly higher in I/R group than in sham group, and was
significantly lower in I/R ? Pre and I/R ? CCR5Ab
groups while higher in I/R ? CCR5Ago group as com-
pared to I/R group (Fig. 6).
CCR5 protein level of myocardial tissues
We also determined the membrane protein levels of CCR5
in myocardial tissue from LV free wall (Fig. 7). The
specific protein expression levels of CCR5 were normal-
ized to b-actin. There is no difference in expression levels
of membrane protein CCR5 between sham and I/R groups
which was downregulated in I/R ? Pre and I/R ? CCR
5Ab and I/R ? CCR5Ago groups.
Discussion
Our study showed that blocking CCR5 attenuates while
enhancing CCR5 aggravates myocardial I/R injury through
modulating inflammatory responses in rat heart. Thus,
strategies modulating CCR5 might serve as potential
therapeutic modalities to reducing I/R injury.
Although the precise mechanism of I/R injury has not
been fully revealed, a series of studies have demonstrated
Fig. 4 Inflammatory levels in
myocardial tissues staining by
HE (magnification 9400).
Representative sections from
rats in I/R and I/R ? CCR5Ago
groups presented massive
inflammatory cell infiltration
(arrows) as compared to sham
group indicating that I/R injury
could trigger the inflammatory
response which was reduced in
I/R ? Pre and I/R ? CCR5Ab
group. Accordingly, histological
score was significantly lower in
I/R ? Pre and I/R ? CCR5Ab
groups than in I/R group and
higher in I/R ? CCR5Ago
group than in I/R ? Pre and
I/R ? CCR5Ab groups
Fig. 5 Myocardial ICAM-1
expression. Brown particles
indicated the expression levels
of ICAM-1 in myocardial
tissues from LV free wall.
Myocardial ICAM-1 expression
was significantly upregulated in
I/R group compared to sham
group and was significantly
attenuated in I/R ? Pre group
and I/R ? CCR5Ab group
while was significantly
increased in I/R ? CCR5Ago
group than in I/R group. (Color
figure online)
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that I–R could activate the intrinsic inflammatory network.
The adhesion and aggregation of neutrophils in the cardiac
tissue might be one of the important factors mediating
myocardial I/R injury [17]. CCR5 is a receptor for various
proinflammatory chemokines. Blocking CCR5 has been
proposed as a novel therapeutic approach for cardiovas-
cular conditions by interfering with systemic inflammation.
This concept is supported by an animal study by Veillard
et al. [18] in which treatment of hypercholesterolemic mice
with the CCR5 antagonist Met-RANTES reduced pro-
gression of atherosclerosis and CCL5/RANTES inhibition
attenuated myocardial reperfusion injury in atherosclerotic
mice [14]. Moreover, treatment of apoE-deficient mice
with Met-RANTES reduced neointimal plaque area and
macrophage infiltration [19] and treatment with TAK-799,
a CCR5 chemokine receptor antagonist, reduced lesion
development in a collar-induced carotid artery atheroscle-
rosis model [20]. Finally, TAK-779 treatment also reduced
leukocyte infiltration and ischemic injury in a mouse model
of focal cerebral ischemia [11]. In line with the above
findings, we demonstrated that CCR5 antibody effectively
reduced myocardial inflammatory cell infiltration and
myocardial infarct size in this rat I/R model. It is to note
that CCR5 activation was not evidenced in this I/R model;
however, our results showed that CCR5 antibody treatment
reduced myocardial injury in this model by reducing
inflammatory responses. The exact mechanism responsible
for the CCR5 antibody treatment effects in this model
warrants further studies. Previous studies found that stim-
ulation of increased TNF-a activity could upregulate
ICAM-1 expression which then could function as an
adhesion molecule promoting neutrophils infiltration [9].
Treatment with specific antibody of ICAM-1 resulted in
coronary vascular and myocardial protection as shown by
the decrease of myocardial infarct size [21]. Similarly, we
showed that treatment with CCR5 antibody significantly
reduced the myocardial expression of ICAM-1. In addition,
MPO activity (an indicator of neutrophil accumulation in
tissue) decreased significantly in both the risk area and
infarcted area in I/R ? Pre and I/R ? CCR5Ab groups
while increased in I/R ? CCR5Ago group compared with
I/R group. Thus, CCR5 antibody reduced while CCR5
agonist enhanced the inflammation in ischemic hearts by
down- or upregulating the expression of TNF-a and ICAM-
1. Taken together, treatment with CCR5 antibody that
reduced infiltration of neutrophils in the ischemic myo-
cardium might contribute to the reduced infarcted size and
serum level of CK in this rat I/R model.
Conclusion
In conclusion, our study provides the first evidence that
CCR5 antibody could reduce cardiac inflammation and
protect the heart from I/R injury via inhibition of the
Fig. 6 Myocardial NF-jB
binding activities. The
myocardial DNA-binding
activity of NF-jB was
significantly higher in I/R group
than in sham group, and was
significantly lower in I/R ? Pre
and I/R ? CCR5Ab groups
while higher I/R ? CCR5Ago
group as compared to I/R group
Fig. 7 CCR5 protein level of myocardial tissues. The specific protein
expression levels of CCR5 were normalized to b-actin. There is no
difference in expression levels of membrane protein CCR5 between
sham and I/R groups which was downregulated in I/R ? Pre and
I/R ? CCR5Ab and I/R ? CCR5Ago groups
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activity of NF-jB, ICAM-1 expression, and MPO activities
in this rat I/R model. We propose that targeting CCR5
might serve as a potential novel promising strategy for the
treatment of ischemic myocardial disease.
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